Gonzalez-Bocco, I. H., Frierson, R., Cho, A., Curcio, F. A. R., Franceschi, A. E., Lahoud, C., . . . Koo, S. An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity. Elsevier.
Chicago Style (17th ed.) CitationGonzalez-Bocco, Isabel H., et al. An Open-label Phase II Trial of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 Infection in Immunocompromised Individuals with Impaired SARS-CoV-2 Humoral Immunity. Elsevier.
MLA (9th ed.) CitationGonzalez-Bocco, Isabel H., et al. An Open-label Phase II Trial of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 Infection in Immunocompromised Individuals with Impaired SARS-CoV-2 Humoral Immunity. Elsevier.
Warning: These citations may not always be 100% accurate.